15:37 EDT X4 Pharmaceuticals (XFOR) trading halted, news pending
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XFOR:
- X4 Pharmaceuticals Announces $60M Equity Financing
- X4 Pharmaceuticals announces $60M financing, management changes
- X4 Pharmaceuticals Advances Phase 3 Study for WHIM Syndrome Treatment
- X4 Pharmaceuticals Advances Phase 3 Study of Mavorixafor for WHIM Syndrome
- X4 Pharmaceuticals Completes Key Study on Mavorixafor’s Drug Interaction Potential